Guggenheim Capital’s NxStage Medical Inc. NXTM Stock Holding History

Guggenheim Capital’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-24,696	Closed	-$707K	–	2263
2018 Q4	$707K	Buy	24,696 +1,743	+8%	+$49.5K	0.01%	1524
2018 Q3	$640K	Sell	22,953 -63	-0.3%	-$1.77K	﹤0.01%	1845
2018 Q2	$643K	Sell	23,016 -174	-0.8%	-$4.67K	﹤0.01%	1810
2018 Q1	$577K	Buy	23,190 +11,943	+106%	+$290K	﹤0.01%	2329
2017 Q4	$273K	Buy	11,247 +2,949	+36%	+$77.7K	﹤0.01%	2517
2017 Q3	$228K	Buy	+8,298	New	+$221K	﹤0.01%	2596
2017 Q1	–	Sell	-7,801	Closed	-$204K	–	2964
2016 Q4	$204K	Sell	7,801 -363	-4%	-$8.98K	﹤0.01%	2687
2016 Q3	$204K	Buy	+8,164	New	+$190K	﹤0.01%	2656

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Guggenheim Capital's NXTM Position: Q1 2019 in Review

Guggenheim Capital sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 24,696 shares — an estimated $707K sold.

Guggenheim Capital first reported a position in NXTM in Q3 2016 and held it in 8 quarters. The position peaked at $707K in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Guggenheim Capital reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Guggenheim Capital sold 24,696 NxStage Medical Inc. shares in Q1 2019, an estimated $707K.
Guggenheim Capital first reported a position in NxStage Medical Inc. in Q3 2016 and held it in 8 quarters.
Guggenheim Capital's NxStage Medical Inc. position peaked at $707K in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Guggenheim Capital's 13F filing for Q1 2019, filed 15 May 2019.